For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Publishing research using ab120182? Please let us know so that we can cite the reference in this datasheet.
ab120182 has been referenced in 1 publication.
- York B et al. Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD. Sci Rep 7:11793 (2017).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"